Verona Pharma plc (I9SA) — Capital Reinvestment Ratio

Latest as of September 2021: 0.00x

Verona Pharma plc (I9SA) has a Capital Reinvestment Ratio of 0.00x as of September 2021, meaning it reinvests 0% of its operating cash flow (€22.82 Million) in capital expenditures (€11.00K). See Verona Pharma plc (I9SA) balance sheet quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

€22.82 Million

EUR

Capital Expenditures

€11.00K

EUR

Data as of

Sep 2021

Most recent filing

Annual Capital Reinvestment Ratio for Verona Pharma plc (None–None)

Year-by-year Capital Reinvestment Ratio for Verona Pharma plc from None to None. For live market cap and broader valuation context, see I9SA market cap.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow